BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7798789)

  • 1. Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
    Thaiss F; Mihatsch MJ; Oberle G; Haberstroh U; Brecht HM; Stahl RA
    J Lab Clin Med; 1994 Dec; 124(6):775-81. PubMed ID: 7798789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
    Yoo J; Schlondorff D; Neugarten J
    J Pharmacol Exp Ther; 1991 Mar; 256(3):841-4. PubMed ID: 2005583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probucol in renal function and structure in rats with subtotal kidney ablation.
    Modi KS; Schreiner GF; Purkerson ML; Klahr S
    J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of proteinases in renal hypertrophy and matrix accumulation.
    Schafer L; Lorenz T; Daemmrich J; Heidland A; Schaefer RM
    Nephrol Dial Transplant; 1995; 10(6):801-7. PubMed ID: 7566607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS.
    Saumweber DM; Bergmann R; Gokel M; Hammer C
    Transplantation; 1994 Feb; 57(3):358-63. PubMed ID: 8108870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of differing classes of antihypertensive agents on mesangial kinetics following partial renal ablation in rats.
    Odum J; Purkiss J; Naish PF
    Nephrol Dial Transplant; 1994; 9(2):131-7. PubMed ID: 8190327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Chávez-Cartaya RE; Metcalfe S; Ramirez-Romero P; Calne R; Jamieson NV
    Transplantation; 1994 May; 57(10):1440-4. PubMed ID: 8197604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular mRNA expression of angiotensinase A after renal ablation.
    Wolf G; Thaiss F; Mueller E; Disser M; Pooth R; Zahner G; Stahl RA
    Exp Nephrol; 1995; 3(4):240-8. PubMed ID: 8590037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro modulation of interleukin-1 beta secretion by cultured rat doxorubicin-stimulated whole glomeruli and dissociated mesangial glomerular cells.
    Bricio T; Molina A; Martin A; Mampaso F
    Immunology; 1994 Jan; 81(1):53-7. PubMed ID: 8132220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids.
    van Goor H; Fidler V; Weening JJ; Grond J
    Lab Invest; 1991 Jun; 64(6):754-65. PubMed ID: 2046327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age is a determinant of the glomerular morphologic and functional responses to chronic nephron loss.
    O'Donnell MP; Kasiske BL; Raij L; Keane WF
    J Lab Clin Med; 1985 Sep; 106(3):308-13. PubMed ID: 4031632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of probucol on mRNA expression of glomerular antioxidant enzymes in rat with subtotal nephrectomy.
    Tang Z; Ji D; Li L; Fukui M; Tomino Y; Koide H
    Chin Med J (Engl); 1996 Oct; 109(10):780-6. PubMed ID: 9275355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation.
    Walcher F; Marzi I; Fischer R; Bauer M; Larsen R
    J Surg Res; 1996 Feb; 61(1):244-9. PubMed ID: 8769973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats.
    Podjarny E; Hasdan G; Bernheim J; Rashid G; Green J; Korzets Z; Bernheim J
    Nephrol Dial Transplant; 2004 Sep; 19(9):2223-7. PubMed ID: 15252157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
    Carter MB; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 1996 Feb; 60(2):403-8. PubMed ID: 8598677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.